PSRC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.29950503083387E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.58649999990746E-08 |
Normal-vs-Stage2 |
4.359800E-03 |
Normal-vs-Stage3 |
3.14189999994774E-06 |
Normal-vs-Stage4 |
1.76390002604165E-09 |
Stage1-vs-Stage2 |
9.517000E-01 |
Stage1-vs-Stage3 |
8.341900E-02 |
Stage1-vs-Stage4 |
3.829800E-04 |
Stage2-vs-Stage3 |
2.348200E-01 |
Stage2-vs-Stage4 |
1.228230E-02 |
Stage3-vs-Stage4 |
1.467440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.38200006993827E-10 |
Normal-vs-AfricanAmerican |
1.87819999997174E-06 |
Normal-vs-Asian |
3.034200E-02 |
Caucasian-vs-AfricanAmerican |
5.833800E-01 |
Caucasian-vs-Asian |
1.163840E-01 |
AfricanAmerican-vs-Asian |
1.141960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.79320011564721E-10 |
Normal-vs-Female |
1.94109994744451E-09 |
Male-vs-Female |
6.688600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.916300E-03 |
Normal-vs-Age(41-60Yrs) |
2.13099999868405E-08 |
Normal-vs-Age(61-80Yrs) |
2.67340038995201E-10 |
Normal-vs-Age(81-100Yrs) |
5.283700E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.416600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.331400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.313400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.992800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.123400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.647200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.646300E-04 |
Normal-vs-Grade 2 |
5.87990000022742E-07 |
Normal-vs-Grade 3 |
4.74340000611306E-09 |
Normal-vs-Grade 4 |
8.15559999534088E-08 |
Grade 1-vs-Grade 2 |
2.255200E-01 |
Grade 1-vs-Grade 3 |
9.789000E-01 |
Grade 1-vs-Grade 4 |
2.133400E-01 |
Grade 2-vs-Grade 3 |
2.468100E-02 |
Grade 2-vs-Grade 4 |
1.899800E-03 |
Grade 3-vs-Grade 4 |
8.064100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.37589999960453E-07 |
Normal-vs-ccB subtype |
5.21260000052592E-07 |
ccA subtype-vs-ccB subtype |
3.528200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.24099969084557E-10 |
Normal-vs-N1 |
4.439900E-03 |
N0-vs-N1 |
2.824000E-01 |
|
|